Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

251.77 +6.04 (+2.46%)
Streaming Delayed Price Updated: 10:28 AM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
News headline image
$100 Invested In ResMed 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
From ResMed Inc.
Via GlobeNewswire
News headline image
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
From ResMed Inc.
Via GlobeNewswire
News headline image
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
News headline image
$100 Invested In ResMed 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Hopeful Golden Cross Forms On ResMed's Chart ↗
 
Via Benzinga
News headline image
A Preview Of ResMed's Earnings ↗
 
Via Benzinga
News headline image
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
From ResMed Inc.
Via GlobeNewswire
News headline image
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
From ResMed Inc.
Via GlobeNewswire
News headline image
ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023
From ResMed Inc.
Via GlobeNewswire
News headline image
Where ResMed Stands With Analysts ↗
ResMed (NYSE:RMD) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Competitor Recall Continues To Show Opportunities For ResMed ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 11, 2022 ↗
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
News headline image
Earnings Scheduled For January 26, 2023 ↗
Companies Reporting Before The Bell • Nokia (NYSE:NOK) is estimated to report quarterly earnings at $0.14 per share on revenue of $7.20 billion. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023 ↗
 
Via Benzinga
News headline image
ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
News headline image
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
From ResMed Inc.
Via GlobeNewswire
News headline image
Looking Into ResMed's Return On Capital Employed ↗
According to Benzinga Pro, during Q1, ResMed (NYSE:RMD) earned $210.48 million, a 7.9% increase from the preceding quarter. ResMed also posted a total of $950.29 million in sales, a 3.89% increase... 
Via Benzinga
News headline image
Company Report Roundup: Tesla, Tractor Supply, American Express, and More ↗
Plus a look at investing books, stocks to watch, and other topics for investors. 
Via The Motley Fool
News headline image
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
From ResMed Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Earnings Scheduled For October 27, 2022 ↗
Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million. 
Via Benzinga
News headline image
ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
From ResMed Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Silk Road Medical Stock Scores Relative Strength Rating Upgrade ↗
Silk Road Medical sees its Relative Strength Rating reach the elite 90-plus level. 
Via Investor's Business Daily
News headline image
Hopeful Golden Cross Forms On ResMed's Chart ↗
If history is any guide, there may be good fortune ahead for shares of ResMed (NYSE:RMD). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock. 
Via Benzinga
News headline image
Tuesday Is Your Last Chance To Buy ResMed Before The Dividend Payout ↗
  Tuesday marks the last chance for investors to receive the next dividend payout from ResMed (NYSE:RMD). 
Via Benzinga
News headline image
$100 Invested In This Stock 20 Years Ago Would Be Worth $3,400 Today ↗
ResMed (NYSE:RMD) has outperformed the market over the past 20 years by 11.43% on an annualized basis producing an average annual return of 19.33%. Currently, ResMed has a market capitalization of... 
Via Benzinga
News headline image
How Is The Market Feeling About ResMed? ↗
ResMed's (NYSE:RMD) short percent of float has fallen 6.8% since its last report. The company recently reported that it has 1.39 million shares sold short, which is 0.96% of all... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022 ↗
  
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.